PCOSCHALLENGE: The PCOS Challenge Study

Sponsor
PCOS Challenge: The National Polycystic Ovary Syndrome Association (Other)
Overall Status
Recruiting
CT.gov ID
NCT05797909
Collaborator
(none)
15,000
1
246.3
60.9

Study Details

Study Description

Brief Summary

The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians.

The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    15000 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    The PCOS Challenge Study: For the Collection of Information to Advance Research and Improve Care for PCOS Patients
    Actual Study Start Date :
    Jun 22, 2022
    Anticipated Primary Completion Date :
    Jun 1, 2042
    Anticipated Study Completion Date :
    Dec 31, 2042

    Arms and Interventions

    Arm Intervention/Treatment
    Target Population

    The target population includes individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or who are exhibiting PCOS Symptoms and willing to sign the consent.

    Control Population

    The control population includes people born biologically female who have not been diagnosed with PCOS and who also do not have symptoms of PCOS.

    Outcome Measures

    Primary Outcome Measures

    1. Information [One Year]

      Such as responses to survey questions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 80 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Diagnosed with PCOS by a health professional, self-diagnosed with PCOS or individuals with PCOS symptoms

    • Willing to sign the consent form

    • Able to understand the registry surveys or what is being asked

    Exclusion Criteria:
    • Unable to understand the surveys or what is being asked

    • Unwilling to sign the consent form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 PCOS Challenge: The National Polycystic Ovary Syndrome Association Bethesda Maryland United States 20817

    Sponsors and Collaborators

    • PCOS Challenge: The National Polycystic Ovary Syndrome Association

    Investigators

    • Principal Investigator: Sasha Ottey, MHA, MT (ASCP), PCOS Challenge: The National Polycystic Ovary Syndrome Association
    • Principal Investigator: Ricardo Azziz, MD, MPH, MBA, The University of Alabama at Birmingham

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    PCOS Challenge: The National Polycystic Ovary Syndrome Association
    ClinicalTrials.gov Identifier:
    NCT05797909
    Other Study ID Numbers:
    • PCOSC001
    First Posted:
    Apr 4, 2023
    Last Update Posted:
    Apr 4, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by PCOS Challenge: The National Polycystic Ovary Syndrome Association
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 4, 2023